Trillium therapeutics stock
WebMay 6, 2024 · About Trillium Therapeutics. Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s two clinical programs, TTI-621 and TTI-622, target ... WebTrillium Therapeutics Stock Rating. What analysts recommend for TRIL stock, on a scale from 1(buy) to 5(sell). Hold. 0% Strong Buy. 0% Buy. 100% Hold. 0% Sell. 0% Strong Sell. …
Trillium therapeutics stock
Did you know?
Webbiocqr: CD47> Stanford mouse study using anti-CD47 (no chemo) for HSC/bone marrow transplants... Bone Marrow Transplants – Without Chemotherapy Side Ef... WebAug 23, 2024 · Pfizer says Monday it will buy Trillium Therapeutics in a deal that values the immuno-oncology specialists at around $2.3 billion. ... a 204% premium to the stock's Friday closing price.
WebTrillium Therapeutic stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Trillium Therapeutics Inc. is a clinical stage … WebAug 23, 2024 · August 23, 2024 06:45 AM Eastern Daylight Time. NEW YORK & CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Pfizer Inc. (NYSE: PFE) and Trillium Therapeutics Inc. …
Web2,000. 2488 DUNWIN DRIVE, MISSISSAUGA, CANADA L5L 1J9. (416) 595-0627. www.trilliumtherapeutics.com. • *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know. Trillium Therapeutics Inc. is a clinical stage immuno-oncology company, which engages in the development of innovative ... WebSep 9, 2024 · Trillium Therapeutics stock forecast. Three analysts forecast the average price in 12 months at $15.00 with a high forecast of $15.00 and a low forecast of $15.00.
WebGet Trillium Therapeutics Inc historical price data for TRIL stock. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change.
WebApr 14, 2024 · Regulus Therapeutics Stock Up 35.5 %. The firm has a market cap of $20.54 million, a price-to-earnings ratio of -0.64 and a beta of 1.54. The business has a 50 day moving average price of $1.19 ... massimo tonettoWebTrillium Therapeutics Inc share price live 23.33, this page displays TSX TRIL stock exchange data. View the TRIL premarket stock price ahead of the market session or assess the … massimo tognacciWebAug 23, 2024 · Pfizer, which acquired a $25 million stake in Trillium last year, will buy the remaining outstanding shares for $18.50 apiece, representing a 203.8% premium on the … datepicker codeigniterWebApr 12, 2024 · Celldex Therapeutics' estimated fair value is US$54.52 based on 2 Stage Free Cash Flow to Equity. Celldex Therapeutics is estimated to be 42% undervalued based on current share price of US$31.41 ... massimo tofanelliWebAug 23, 2024 · Pfizer said early Monday that it had agreed to purchase cancer-focused biotech Trillium Therapeutics for $2.3 billion in cash, or $18.50 a share, a 118% premium … datepicker color flutterWebDec 11, 2024 · Trillium Therapeutics Inc. TRIL was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far … massimo toffoloWebDec 22, 2024 · What have hedge funds been doing with Trillium Therapeutics Inc. (NASDAQ:TRIL)? At the end of the third quarter, a total of 4 of the hedge funds tracked by … datepicker calendar